Search

Search Constraints

You searched for: Author/Creator Bamias, A

Search Results

1. 865PDRANGE, a phase III, randomized, placebo-controlled, double-blind trial of ramucirumab (RAM) and docetaxel (DOC) in platinum-refractory urothelial carcinoma (UC): Overall survival results. (23rd October 2018)

2. 884PReal-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). (23rd October 2018)

3. 970PEvaluation of chemotherapy response score and lymphocytic infiltration as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy. (23rd October 2018)

5. Association of COVID-19 with impaired endothelial glycocalyx, coronary flow and longitudinal strain four months after infection. (4th February 2022)

6. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial efficiency four months after infection. (4th February 2022)

7. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021)

8. COVID-19 patients present impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation resembling those observed in hypertensives four months after infection. (14th October 2021)

9. Differential effect of anthracycline and trastuzumab cancer therapeutic related vascular toxicity in patients with breast cancer. (25th November 2020)

10. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (19th November 2019)